Francisco Javier Campoy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Francisco Javier Campoy has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Cecilio J. Vidal
Departamento de Bioquímica y Biología Molecular-A, Universidad de Murcia, IMIB-Arrixaca, Regional Campus of International Excellence "Campus Mare Nostrum", Murcia, Spain
41 shared publications - Encarnación Muñoz-Delgado
Departamento de Bioquímica y Biología Molecular-A, Universidad de Murcia, Murcia, Spain
29 shared publications - Juan Cabezas-Herrera
Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain
16 shared publications - Maria Fernanda Montenegro
Department of Biochemistry and Molecular Biology A, School of Biology, University of Murcia, Instituto Murciano de Investigación Biosanitaria (IMIB), Murcia, Spain
16 shared publications - María Teresa Moral‐Naranjo
Departamento de Bioquímica y Biología Molecular-A, Universidad de Murcia, Murcia, Spain
14 shared publications - Susana Nieto
Departamento de Bioquímica y Biología Molecular “B” e Inmunología, Facultad de Química, Universidad de Murcia, 30100 Murcia, Spain
7 shared publications
Latest Publications
- 1 November 2016
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 259, 257-265
Cholinergic system and cell proliferation
- 1 November 2016
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 259, 257-265
Cholinergic system and cell proliferation
- Open Access
- 25 October 2016
- Published by Wiley in The FASEB Journal
- Vol. 31 (2) , 544-555
Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors
The observation of acetylcholinesterase (AChE) type H (AChEH), which is the predominant AChE variant in visceral organs and immune cells, in lipid rafts of muscle supports functional reasons for the raft targeting of glypiated AChEH. The search for these reasons revealed that liver AChE activity is mostly confined to rafts and that the liver is able to make N‐extended AChE variants and target them to rafts. These results prompted us to test whether AChE and muscarinic receptors existed in the same raft. Isolation of flotillin2‐rich raft fractions by their buoyancy in sucrose gradients, followed by immunoadsorption and matrix‐assisted laser desorption ionization‐time of flight‐mass spectrometry application, gave the following results: 1) most hepatic AChE activity emanates from AChE‐H mRNA, and its product, glypiated AChEH, accumulates in rafts; 2) N‐extended N‐AChE readthrough variant, nonglypiated N‐AChEH, and N‐AChE tailed variant were all identified in liver rafts; and 3) M3 AChRs were observed in rafts, and coprecipitation of raft‐confined N‐AChE and M3 receptors by using anti‐M3 antibodies showed that enzyme and receptor reside in the same raft unit. A raft domain that harbors tightly packed muscarinic receptor and AChE may represent a molecular device that, by means of which, the intensity and duration of cholinergic inputs are regulated.—Montenegro, M. F., Cabezas‐Herrera, J., Campoy, F. J., Muñoz‐Delgado, E., Vidal, C. J. Lipid rafts of mouse liver contain non‐extended and extended acetylcholinesterase variants along with M3 muscarinic receptors. FASEB J. 31, 544–555(2017). www.fasebj.org
- 25 October 2016
- Published by Wiley in The FASEB Journal
- Vol. 31 (2) , 544-555
Open AccessLipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors
The observation of acetylcholinesterase (AChE) type H (AChEH), which is the predominant AChE variant in visceral organs and immune cells, in lipid rafts of muscle supports functional reasons for the raft targeting of glypiated AChEH. The search for these reasons revealed that liver AChE activity is mostly confined to rafts and that the liver is able to make N‐extended AChE variants and target them to rafts. These results prompted us to test whether AChE and muscarinic receptors existed in the same raft. Isolation of flotillin2‐rich raft fractions by their buoyancy in sucrose gradients, followed by immunoadsorption and matrix‐assisted laser desorption ionization‐time of flight‐mass spectrometry application, gave the following results: 1) most hepatic AChE activity emanates from AChE‐H mRNA, and its product, glypiated AChEH, accumulates in rafts; 2) N‐extended N‐AChE readthrough variant, nonglypiated N‐AChEH, and N‐AChE tailed variant were all identified in liver rafts; and 3) M3 AChRs were observed in rafts, and coprecipitation of raft‐confined N‐AChE and M3 receptors by using anti‐M3 antibodies showed that enzyme and receptor reside in the same raft unit. A raft domain that harbors tightly packed muscarinic receptor and AChE may represent a molecular device that, by means of which, the intensity and duration of cholinergic inputs are regulated.—Montenegro, M. F., Cabezas‐Herrera, J., Campoy, F. J., Muñoz‐Delgado, E., Vidal, C. J. Lipid rafts of mouse liver contain non‐extended and extended acetylcholinesterase variants along with M3 muscarinic receptors. FASEB J. 31, 544–555(2017). www.fasebj.org
- 16 November 2013
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 53 (3) , 429-435
Most Acetylcholinesterase Activity of Non-Nervous Tissues and Cells Arises from the AChE-H Transcript
While the functional implications of AChE-T, PRiMA and ColQ have been firmly established, those of glypiated AChE remain uncertain. Insights into the physiological meaning of glycosylphosphatidylinositol (GPI)-linked AChE-H were gained by comparing nervous and non-nervous tissues for the amount of AChE mRNA variants they contained. PCR showed that AChE-T mRNA prevailed in the mouse brain, spinal cord, sciatic nerve and muscle, and AChE-H mRNA in the bone marrow and thymus, as well as in the human gut. The similar levels of AChE-T and AChE-H mRNAs in mouse liver and human kidney contrasted with the almost exclusive presence of catalytically active AChE-H in both organs. The absence of PRiMA mRNA in liver suggested that the tetramers made of AChE-T fail to bind to the cell membrane and are secreted due to the lack of PRiMA in non-nervous organs. In contrast, glypiated AChE-H is largely and lastingly bound to the cell membrane. Thus, non-synaptic glypiated AChE-H seems to be the counterpart of synaptic PRiMA-linked AChE-T, the former designed for clearing ACh waves, the latter for confronting ACh bursts, and both for helping to protect cells against the harmful effects of durable nicotinic and muscarinic activation.
- 16 November 2013
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 53 (3) , 429-435
Most Acetylcholinesterase Activity of Non-Nervous Tissues and Cells Arises from the AChE-H Transcript
While the functional implications of AChE-T, PRiMA and ColQ have been firmly established, those of glypiated AChE remain uncertain. Insights into the physiological meaning of glycosylphosphatidylinositol (GPI)-linked AChE-H were gained by comparing nervous and non-nervous tissues for the amount of AChE mRNA variants they contained. PCR showed that AChE-T mRNA prevailed in the mouse brain, spinal cord, sciatic nerve and muscle, and AChE-H mRNA in the bone marrow and thymus, as well as in the human gut. The similar levels of AChE-T and AChE-H mRNAs in mouse liver and human kidney contrasted with the almost exclusive presence of catalytically active AChE-H in both organs. The absence of PRiMA mRNA in liver suggested that the tetramers made of AChE-T fail to bind to the cell membrane and are secreted due to the lack of PRiMA in non-nervous organs. In contrast, glypiated AChE-H is largely and lastingly bound to the cell membrane. Thus, non-synaptic glypiated AChE-H seems to be the counterpart of synaptic PRiMA-linked AChE-T, the former designed for clearing ACh waves, the latter for confronting ACh bursts, and both for helping to protect cells against the harmful effects of durable nicotinic and muscarinic activation.
- 1 March 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 203 (1) , 330-334
The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency
- 1 March 2013
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 203 (1) , 330-334
The AChE membrane-binding tail PRiMA is down-regulated in muscle and nerve of mice with muscular dystrophy by merosin deficiency
- Open Access
- 7 September 2010
- Published by Wiley in The FEBS Journal
- Vol. 277 (21) , 4519-4529
Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types
Despite the aberrant expression of cholinesterases in tumours, the question of their possible contribution to tumorigenesis remains unsolved. The identification in kidney of a cholinergic system has paved the way to functional studies, but details on renal cholinesterases are still lacking. To fill the gap and to determine whether cholinesterases are abnormally expressed in renal tumours, paired pieces of normal kidney and renal cell carcinomas (RCCs) were compared for cholinesterase activity and mRNA levels. In studies with papillary RCC (pRCC), conventional RCC, chromophobe RCC, and renal oncocytoma, acetylcholinesterase activity increased in pRCC (3.92 ± 3.01 mU·mg−1, P = 0.031) and conventional RCC (2.64 ± 1.49 mU·mg−1, P = 0.047) with respect to their controls (1.52 ± 0.92 and 1.57 ± 0.44 mU·mg−1). Butyrylcholinesterase activity increased in pRCC (5.12 ± 2.61 versus 2.73 ± 1.15 mU·mg−1, P = 0.031). Glycosylphosphatidylinositol‐linked acetylcholinesterase dimers and hydrophilic butyrylcholinesterase tetramers predominated in control and cancerous kidney. Acetylcholinesterase mRNAs with exons E1c and E1e, 3′‐alternative T, H and R acetylcholinesterase mRNAs and butyrylcholinesterase mRNA were identified in kidney. The levels of acetylcholinesterase and butyrylcholinesterase mRNAs were nearly 1000‐fold lower in human kidney than in colon. Whereas kidney and renal tumours showed comparable levels of acetylcholinesterase mRNA, the content of butyrylcholinesterase mRNA was increased 10‐fold in pRCC. The presence of acetylcholinesterase and butyrylcholinesterase mRNAs in kidney supports their synthesis in the organ itself, and the prevalence of glycosylphosphatidylinositol‐anchored acetylcholinesterase explains the splicing to acetylcholinesterase‐H mRNA. The consequences of butyrylcholinesterase upregulation for pRCC growth are discussed.Structured digital abstract MINT‐7992181: BuChE (uniprotkb:P06276) and BuChE (uniprotkb:P06276) bind (MI:0407) by chromatography technology (MI:0091) MINT‐7992175: AChE (uniprotkb:P22303) and AChE (uniprotkb:P22303) bind (MI:0407) by chromatography technology (MI:0091)
- 7 September 2010
- Published by Wiley in The FEBS Journal
- Vol. 277 (21) , 4519-4529
Open AccessExpression of cholinesterases in human kidney and its variation in renal cell carcinoma types
Despite the aberrant expression of cholinesterases in tumours, the question of their possible contribution to tumorigenesis remains unsolved. The identification in kidney of a cholinergic system has paved the way to functional studies, but details on renal cholinesterases are still lacking. To fill the gap and to determine whether cholinesterases are abnormally expressed in renal tumours, paired pieces of normal kidney and renal cell carcinomas (RCCs) were compared for cholinesterase activity and mRNA levels. In studies with papillary RCC (pRCC), conventional RCC, chromophobe RCC, and renal oncocytoma, acetylcholinesterase activity increased in pRCC (3.92 ± 3.01 mU·mg−1, P = 0.031) and conventional RCC (2.64 ± 1.49 mU·mg−1, P = 0.047) with respect to their controls (1.52 ± 0.92 and 1.57 ± 0.44 mU·mg−1). Butyrylcholinesterase activity increased in pRCC (5.12 ± 2.61 versus 2.73 ± 1.15 mU·mg−1, P = 0.031). Glycosylphosphatidylinositol‐linked acetylcholinesterase dimers and hydrophilic butyrylcholinesterase tetramers predominated in control and cancerous kidney. Acetylcholinesterase mRNAs with exons E1c and E1e, 3′‐alternative T, H and R acetylcholinesterase mRNAs and butyrylcholinesterase mRNA were identified in kidney. The levels of acetylcholinesterase and butyrylcholinesterase mRNAs were nearly 1000‐fold lower in human kidney than in colon. Whereas kidney and renal tumours showed comparable levels of acetylcholinesterase mRNA, the content of butyrylcholinesterase mRNA was increased 10‐fold in pRCC. The presence of acetylcholinesterase and butyrylcholinesterase mRNAs in kidney supports their synthesis in the organ itself, and the prevalence of glycosylphosphatidylinositol‐anchored acetylcholinesterase explains the splicing to acetylcholinesterase‐H mRNA. The consequences of butyrylcholinesterase upregulation for pRCC growth are discussed.Structured digital abstract MINT‐7992181: BuChE (uniprotkb:P06276) and BuChE (uniprotkb:P06276) bind (MI:0407) by chromatography technology (MI:0091) MINT‐7992175: AChE (uniprotkb:P22303) and AChE (uniprotkb:P22303) bind (MI:0407) by chromatography technology (MI:0091)
- 1 September 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1802 (9) , 754-764
The levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency
- 1 September 2010
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1802 (9) , 754-764
The levels of both lipid rafts and raft-located acetylcholinesterase dimers increase in muscle of mice with muscular dystrophy by merosin deficiency
- 16 July 2009
- Published by Wiley in Journal of Neuroscience Research
- Vol. 88 (1) , 155-166
Cholinesterase activity in brain of senescence‐accelerated‐resistant mouse SAMR1 and its variation in brain of senescence‐accelerated‐prone mouse SAMP8
The early‐onset, irreversible, severe deficits of learning and memory in the senescence‐accelerated mouse (SAM)‐prone/8 (SAMP8) support its use as an animal model for human dementias of early onset. Possible implication of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) in cognitive dysfunction of SAMP8 mice was studied by comparing cholinesterase (ChE) expression in brains of SAMP8 mice and of their normal control, SAM‐resistant/1 (SAMR1) mice. The level of ChE mRNAs was the same in SAMP8 and SAMR1 brains, which agreed with their equal AChE activity (3.09 ± 1.45 vs. 3.07 ± 1.44 μmol·hr−1·mg protein−1, U/mg), but not with a doubled BuChE activity in SAMP8 brain (0.14 ± 0.05 vs. 0.07 ± 0.02 U/mg; P < 0.01). This great increase in neural BuChE activity may contribute to cognitive deficit of SAMP8 mice. Hydrophilic (G, 8%) and amphiphilic (G, 74%) AChE tetramers, besides dimers and monomers (G + G, 18%), were identified in SAMR1 brains. They also contained G BuChE forms (18%) as well as G (53%) and G + G (29%) species. Although SAMP8 brain displayed proportions of AChE and BuChE forms that were similar to those of SAMR1 brain, phenyl‐agarose chromatography with detergent‐free extracts showed a rise in the proportion of secretory G BuChE from 35% in SAMR1 to 44% in SAMP8 brain. The strong immunolabelling of glial fibrillary acidic protein (GFAP), a marker of reactive gliosis, in SAMP8 brain and the consideration of BuChE as a marker of glial cells suggest a relationship between phenotypic changes in neuroglial cells and the excess of BuChE activity in SAMP8 brain.
- 16 July 2009
- Published by Wiley in Journal of Neuroscience Research
- Vol. 88 (1) , 155-166
Cholinesterase activity in brain of senescence‐accelerated‐resistant mouse SAMR1 and its variation in brain of senescence‐accelerated‐prone mouse SAMP8
The early‐onset, irreversible, severe deficits of learning and memory in the senescence‐accelerated mouse (SAM)‐prone/8 (SAMP8) support its use as an animal model for human dementias of early onset. Possible implication of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) in cognitive dysfunction of SAMP8 mice was studied by comparing cholinesterase (ChE) expression in brains of SAMP8 mice and of their normal control, SAM‐resistant/1 (SAMR1) mice. The level of ChE mRNAs was the same in SAMP8 and SAMR1 brains, which agreed with their equal AChE activity (3.09 ± 1.45 vs. 3.07 ± 1.44 μmol·hr−1·mg protein−1, U/mg), but not with a doubled BuChE activity in SAMP8 brain (0.14 ± 0.05 vs. 0.07 ± 0.02 U/mg; P < 0.01). This great increase in neural BuChE activity may contribute to cognitive deficit of SAMP8 mice. Hydrophilic (G, 8%) and amphiphilic (G, 74%) AChE tetramers, besides dimers and monomers (G + G, 18%), were identified in SAMR1 brains. They also contained G BuChE forms (18%) as well as G (53%) and G + G (29%) species. Although SAMP8 brain displayed proportions of AChE and BuChE forms that were similar to those of SAMR1 brain, phenyl‐agarose chromatography with detergent‐free extracts showed a rise in the proportion of secretory G BuChE from 35% in SAMR1 to 44% in SAMP8 brain. The strong immunolabelling of glial fibrillary acidic protein (GFAP), a marker of reactive gliosis, in SAMP8 brain and the consideration of BuChE as a marker of glial cells suggest a relationship between phenotypic changes in neuroglial cells and the excess of BuChE activity in SAMP8 brain.
- Open Access
- 9 March 2009
- Published by Wiley in The FEBS Journal
- Vol. 276 (7) , 2074-2083
Hydrolysis of acetylthiocoline, o‐nitroacetanilide and o‐nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesterase
Besides esterase activity, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) hydrolyze o‐nitroacetanilides through aryl acylamidase activity. We have reported that BuChE tetramers and monomers of human blood plasma differ in o‐nitroacetanilide (ONA) hydrolysis. The homology in quaternary structure and folding of subunits in the prevalent BuChE species () of human plasma and AChE forms of fetal bovine serum prompted us to study the esterase and amidase activities of fetal bovine serum AChE. The kcat/Km values for acetylthiocholine (ATCh), ONA and its trifluoro derivative N‐(2‐nitrophenyl)‐trifluoroacetamide (F‐ONA) were 398 × 106 m−1·min−1, 0.8 × 106 m−1·min−1, and 17.5 × 106 m−1·min−1, respectively. The lack of inhibition of amidase activity at high F‐ONA concentrations makes it unlikely that there is a role for the peripheral anionic site (PAS) in F‐ONA degradation, but the inhibition of ATCh, ONA and F‐ONA hydrolysis by the PAS ligand fasciculin‐2 points to the transit of o‐nitroacetalinides near the PAS on their way to the active site. Sedimentation analysis confirmed substrate hydrolysis by tetrameric 10.9S AChE. As compared with esterase activity, amidase activity was less sensitive to guanidine hydrochloride. This reagent led to the formation of 9.3S tetramers with partially unfolded subunits. Their capacity to hydrolyze ATCh and F‐ONA revealed that, despite the conformational change, the active site architecture and functionality of AChE were partially retained.
- 9 March 2009
- Published by Wiley in The FEBS Journal
- Vol. 276 (7) , 2074-2083
Open AccessHydrolysis of acetylthiocoline, o‐nitroacetanilide and o‐nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesterase
Besides esterase activity, acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) hydrolyze o‐nitroacetanilides through aryl acylamidase activity. We have reported that BuChE tetramers and monomers of human blood plasma differ in o‐nitroacetanilide (ONA) hydrolysis. The homology in quaternary structure and folding of subunits in the prevalent BuChE species () of human plasma and AChE forms of fetal bovine serum prompted us to study the esterase and amidase activities of fetal bovine serum AChE. The kcat/Km values for acetylthiocholine (ATCh), ONA and its trifluoro derivative N‐(2‐nitrophenyl)‐trifluoroacetamide (F‐ONA) were 398 × 106 m−1·min−1, 0.8 × 106 m−1·min−1, and 17.5 × 106 m−1·min−1, respectively. The lack of inhibition of amidase activity at high F‐ONA concentrations makes it unlikely that there is a role for the peripheral anionic site (PAS) in F‐ONA degradation, but the inhibition of ATCh, ONA and F‐ONA hydrolysis by the PAS ligand fasciculin‐2 points to the transit of o‐nitroacetalinides near the PAS on their way to the active site. Sedimentation analysis confirmed substrate hydrolysis by tetrameric 10.9S AChE. As compared with esterase activity, amidase activity was less sensitive to guanidine hydrochloride. This reagent led to the formation of 9.3S tetramers with partially unfolded subunits. Their capacity to hydrolyze ATCh and F‐ONA revealed that, despite the conformational change, the active site architecture and functionality of AChE were partially retained.